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Background. Hepatitis B virus (HBV) infection is a well recognised occupational health hazard preventable by vaccination.
Objectives. To determine the knowledge of operating room personnel (ORP) in Nigeria about the Hepatitis B vaccine, their
perception of Hepatitis B vaccination and vaccination status against HBV. Methods. Four university hospitals were selected by
simple random sampling. A structured questionnaire was administered to 228 ORP after obtaining consent. Result. Only 26.8%
of ORP were vaccinated against HBV. The primary reason for not being vaccinated or for defaulting from vaccination was lack
of time. Diﬀerences in age, sex, duration of practice and respondent’s institution between vaccinated and unvaccinated ORP were
not signiﬁcant (P>0.05). The majority (86.8%) had the awareness of the existence of Hepatitis B vaccine. 83.8% of respondents
believed that the vaccine should be given to the ORP as part of work place safety measures. The majority were aware of the modes
of transmission of HBV infection. 78.9% of respondents believed that Hepatitis B vaccine is safe and 81.1% would recommend
it to another staﬀ. Conclusion. Despite a good knowledge about HBV infection and vaccine, most of ORP are still not vaccinated.
Hepatitis B vaccination should be a prerequisite for working in the theatre, hence putting surgical patients at reduced risk.
1.Introduction
The most serious occupational health hazard faced by
health care workers worldwide is exposure to blood-borne
pathogens. These blood-borne pathogens are mainly Hepati-
tis B, C, and HIV infection.
Hepatitis B is by far the most dreaded with over 2
billion people aﬀected worldwide and 350 million people
suﬀering from chronic hepatitis B virus infection [1]. It is
more infectious than the other blood-borne pathogens and
estimates of the risk of a single needlestick injury indicate a
risk of 300 hepatitis B virus infection (30% risk), 30 hepatitis
C virus infection (3% risk) and 3 HIV infection (0.3% risk),
per 1,000 respective exposures [2].
In the United States, the incidence of HBV infection
among all health care workers is estimated to be 3.5 to 4.6
infections per 1000 workers, which is 2- to 4-times the level
forthegeneralpopulation [3].Thediseaseisthusmorelikely
in health workers in Nigeria, a country with high prevalence
of the disease.
Among health care workers, operating room personnel
are at a high risk of infection with blood-borne pathogens
through blood contact [4]. This group of health workers
has been shown not to follow standard precautions and
not to report all percutaneous injuries [4]. Unfortunately,
researchers have also not shown enough interest in evalu-
ating their knowledge of hepatitis B virus infection or the
vaccine. Most previous studies in health care workers in
developing countries have revealed inadequate knowledge
of hepatitis B virus infection and inadequate practice of
preventive measures against the disease [5–7].
Percutaneous injury is the most eﬃcient mode of hep-
atitis B transmission among operating room personnel. The
risk of developing serologic evidence of HBV infection was2 Hepatitis Research and Treatment
37% to 62% if the blood was positive for both hepatitis B
surface antigen (HBsAg) and hepatitis B e antigen (HBeAg)
and 23% to 37% if the blood was positive for HBsAg and
negative for HBeAg [8].
The most eﬀective and feasible means of preventing HBV
infection is by vaccination and avoidance of exposure to
blood. The vaccine was initially by means of a plasma-
derived HBsAg subunit which has largely been replaced by
recombinant vaccine. This vaccine has been available since
1982 and has generally been described as safe and eﬀective
with a protective eﬃciency of 90–95% [9].
Complete vaccination against hepatitis B is achieved by
administration of a three-dose regimen, with the second
and third doses being given one and six months after the
initial dose. A test for hepatitis B surface antibody (HBsAb)
should be carried out 6–8 weeks following the ﬁnal dose of
the primary course of vaccination [10]. Antibody levels of
over 100miu/mL indicate a good response to vaccination.
Antibody levels between 10 and 100miu/mL indicate a poor
response and a booster dose should be given immediately to
improve response. A blood test should be carried out 6–8
weeks after the booster dose to check response [10].
We aimed to determine, in operating room personnel,
their knowledge of the HBV vaccine, perception of vaccina-
tion, and understanding of risk factors for HBV infection.
To the best of our knowledge, no similar study has been
carried out among operating room personnel in Nigeria.
2.Methodology
2.1. Study Design. Four university hospitals were selected
for the study by simple random sampling. The hospi-
tals included University of Maiduguri Teaching Hospital,
Imo State University Teaching Hospital, University College
Hospital, Ibadan and Irrua Specialist Teaching Hospital
representing the Northern, Eastern, Western, and South-
ern Nigeria, respectively. All the institutions are tertiary
referral centres for training undergraduate and postgraduate
students and for research. All the operating theatre staﬀ
includingsurgeons,anaesthetists,scrubnurses,andauxiliary
staﬀ were eligible for the study.
2.2. Enrolment and Data Collection. After obtaining in-
formed consent, the participating theatre staﬀ completed a
questionnairewhichwasbasedmainlyontheknowledgeand
practice of hepatitis B immunization, knowledge of risk of
exposure, and practice of postexposure prophylaxis. These
questionnaires were distributed and ﬁlled in the operating
room to ensure the participation of most active operating
room personnel.
The following information was requested: demographic
and professional characteristics, duration of work expe-
rience, status of immunization, perception of hepatitis B
vaccine, and their attitude towards recommending hepatitis
B vaccine to other theatre users. Awareness of various risks
for exposure to blood-borne pathogens and practice of
postexposure prophylaxis was explored.
Vaccinatedrespondentswereclassiﬁedinto(a)thosewho
had completed course of vaccination and the antibody test
Table 1: Vaccination status.
Vaccination status
Vaccinated 61 (26.8%)
Not vaccinated 167 (73.2%)
Total 228 (100%)
indicating a good response or (b) those who had completed
a course of vaccination but defaulted on antibody test after
vaccination. Staﬀ who had never been vaccinated or started
the course of vaccination butdefaulted were considered to be
not vaccinated.
2.3. Statistical Analysis. The data from all the returned ques-
tionnaires were entered into SPSS, version 16, and analysed.
Both descriptive and inferential statistics were computed.
The level of signiﬁcance was set at P<0.05.
3. Results
A total of 228 operating room personnel participated in the
study. The majority of staﬀ that participated in the study
weresurgicalresidents (trainee surgeons;32%). Consultants,
house surgeons, and nurses accounted for 12.7%, 10.5%,
and21%ofrespondents,respectively.Othersincludedanaes-
thetists (12.3%), technicians (5.7%), and others (6.6%).
Males accounted for 67.5% while females accounted for
32.5%.
Sixty-one respondents (26.8%) had been vaccinated
while 167 respondents had not been vaccinated (Table 1).
Of the 167 respondents that had not been vaccinated, 103
(61.7%)hadnotcommencedvaccination,55(32.9%)started
vaccination and defaulted and 9 (5.4 %) were in the process
of receiving vaccinations and awaiting further courses.
Among those that were completely vaccinated, 29 respon-
dents had undergone antibody testing which showed good
responsetovaccinationwhereas32respondentsdefaultedon
antibody test after vaccination.
Of the respondents that had been vaccinated, 39 were
males (63.9%) while 22 (36.1%) were females. Respondents
practising for 15–20 years had not been not vaccinated.
Diﬀerencesinage,sex,durationofpractice,andrespondent’s
institution between the vaccinated and unvaccinated ORP
were not statistically signiﬁcant (P>0.05).
One hundred and forty-seven (64.5%) respondents of
the ORP that had not been vaccinated responded to the
reasons for not being vaccinated or for defaulting while on
a vaccination schedule. The primary reasons were mainly
lack of time to attend (33.9%), not enough information
on the vaccination (19.7%), and no idea about existence of
immunization (15%).
Regarding knowledge of hepatitis B vaccine, 86.8% of
respondents were aware of the existence of the vaccine
(Table 2).Allsurgeons(includingtrainees)wereawareofthis
vaccine, but 4 anaesthetists, 9 nurses, and 12 other staﬀ were
unaware of the vaccine (P<0.05).Hepatitis Research and Treatment 3
Table 2: Knowledge of hepatitis B vaccine.
Are you aware of vaccination for hepatitis B
Yes 198 (86.8%)
No 30 (13.2%)
Total 228 (100%)
Hepatitis B vaccine should be given to ORP as part
of work place safety
Yes 191 (83.8%)
No 13 (5.7%)
DNK 24 (10.5%)
Total 228 (100%)
Hepatitis B vaccine can be administered
simultaneously with HBIG (the immunoglobulin)
when indicated
Yes 102 (44.9%)
No 36 (15.9%)
DNK 89 ( 39.2%)
Total 227(100%)
When indicated as part of PEP, it should be
administered within 24hrs of exposure
Yes 116 (50.9%)
No 27 (11.8%)
DNK 85 (37.3%)
Total 227 (100%)
For complete protection, it consists of two doses at 0
and 6 months
Yes 55 (24.6%)
No 71 (31.7%)
DNK 98 (43.8)
Total 224 (100%)
The majority (83.3%) were of the opinion that the vac-
cine should be given to operating room personnel as part of
workplacesafetymeasurewhile44.9%thoughtthathepatitis
B vaccine can be administered simultaneously with hepatitis
B immunoglobulin (HBIG) when indicated (Table 2). Most
respondents also rightly indicated that complete vaccination
does not consist of just 2 doses of the vaccine. Out of these
71 surgical staﬀ, less than half (47%) could correctly state the
intervals between the doses.
The majority had good knowledge of the risk factors
for HBV infection. Some 91.7%, 83.2%, and 84.6% believed
that hepatitis B virus infection can be transmitted through
percutaneous injury, mucous membrane contact with blood,
and contact of abraded skin with potentially infected tissue,
respectively. Seventy-eight point three percent (78.3%) of
respondents thought that they were at a greater risk of
becoming infected with HBV than the general population
(Table 3).
Regarding the perception of the hepatitis B vaccine,
76.8% of the respondents agreed that the vaccine is safe.
Eighty-one point one percent (81.1%) of respondents would
recommend the vaccine to another surgical staﬀ. The rela-
tionship between recommending the vaccine to a colleague
Table 3: Knowledge of risk factors.
Percutaneous injury with blood
Yes 188 (91.7%)
No 17 (8.3%)
Total 205 (100%)
Mucous membrane contact with blood
Yes 168 (83.2%)
No 33 (16.8%)
Total 197 (100%)
Contact of abraded skin with potentially infected
tissue
Yes 170 (84.6%)
No 31 (15.4%)
Total 201 (100%)
Contact of skin aﬄicted with dermatitis with
potentially infected body ﬂuid
Yes 146 (78.1%)
No 41 (21.9%)
Total 187 (100%)
Do you agree you are at risk more than the general
population
Agree 173 (78.3%)
Disagree 27 (12.2%)
DNK 21 (9.5%)
Total 221 (100%)
andperceptionaboutthesafetyofhepatitisvirusvaccinewas
found to be statistically signiﬁcant (P<0.05). Seventy-two
point one percent (72.1%) of respondents did not know how
many of their colleagues that had received hepatitis B vaccine
(Table 4).
4. Discussion
In developed countries like the United States, not only
are there a signiﬁcant percentage of health care workers
(75%) vaccinated against hepatitis B virus infection, but
plans already exist to achieving 98% hepatitis B vaccina-
tion coverage among HCWs, providing a benchmark for
the elimination of occupationally acquired HBV infection
[11]. Seventy-nine percent (79%) of HCWs in Sweden
had received at least one dose of vaccine, but only 40%
were reported to be fully vaccinated [12] while vaccination
coverage was found to be 48.2% in dental workers in Japan
[13]. The story has been diﬀerent in Nigeria [6, 14].
This study has clearly shown a poor vaccination status
(26.8%) among operating theatre personnel, a subset of
health care workers obviously at high risk of occupational
exposure to HBV. This is very disturbing as previous studies
in the country have consistently shown low vaccination
status among health care workers. Adebamowo et al. and
Sofola et al. reported that only 18.1% and 37.9% of their
respondents were reported to be fully vaccinated against
hepatitis B infection in 1998 and 2007, respectively [6, 14].4 Hepatitis Research and Treatment
Table 4: Perception of HBV vaccine.
Do you agree that HBV vaccine is safe
Yes 180 (78.9%)
No 14 (6.1%)
DNK 34 (14.9%)
Total 228 (100%)
I will recommend HBV vaccine to another surgical
staﬀ
Yes 185 (81.1%)
No 16 (7.0%)
DNK 27 (11.8%)
Total 224 (100%)
How many of your colleagues do you think have
received HBV vaccination
Yes 29 (15.8%)
No 22 (12.0%)
DNK 132 (72.1%)
Total 183 (100%)
However studies done in India have revealed better vacci-
nation status [15, 16]. Sukriti et al. reported that only 28%
HCWs in India were unvaccinated and 17% were unaware
of their vaccination status [15]. Singhal et al. reported that
56.5% of health care workers were vaccinated, and in 79%
of those vaccinated persons, protective levels (>10IU/mL) of
anti-hepatitis B surface antigen (anti-HBs) were seen [16].
Wefoundthatmanyofthestaﬀwereunvaccinateddueto
lack of time to attend to vaccination and not having enough
information about hepatitis B vaccine. Other workers have
found busy schedule, lack of knowledge about severity and
vaccine eﬃciency, perception of low-risk status as reasons
for unvaccination, refusal of vaccine due to fear of getting
hepatitis B from the vaccination, and fear of side eﬀects
[7, 17, 18]. Kamolratanakul et al. found out that lack of
knowledge and negative attitudes were the main reasons
for refusal, in a vaccination programme against hepatitis
Bv i r u s[ 19]. These were found to improve signiﬁcantly
after the dissemination of information, with acceptance rates
increasing from 56.9% to 77.7% [19]. The acceptance of
hepatitis B vaccine has been found to be strongly related
to social inﬂuence (physicians, supervisors, role models,
friends, and spouse) and knowledge of the disease and
vaccine whereas refusal has been found to be primarily
related to concern about vaccine side eﬀects and problems
with vaccine access [20].
Our study revealed that most of the respondents had
good knowledge of the risk factors for hepatitis B virus
infection. This contrasts others that have demonstrated a
very low knowledge of hepatitis B infection and poor safe
practices to prevent transmission of the infection [6, 7, 21].
We think that the reason for this is that the majority of our
respondentsweredoctorsornursesandsoaremoreeducated
than the lower cadre of health care workers. This fact is,
however, substantiated by a study by Ibekwe and Ibeziako
in which there was a signiﬁcant occupational diﬀerence in
perception to an increased risk of contracting hepatitis B
virus infection with only 5.5% of the ward attendants as
against67.9%ofotherworkersfeelingthattheirjobsexposed
them to increased risk [22].
Our study revealed that a signiﬁcant percentage of oper-
ating room personnel believed the vaccine to be safe and will
recommend it to another colleague. This may be attributable
to their good knowledge of the vaccine and risk factors
for HBV infection. Perception of vaccine safety has been
identiﬁed as the most important predictor for acceptance
and for willingness to recommend HBV vaccination to other
heath care workers. Vaccinated HCWs were more likely to
recommend vaccination to other healthcare personnel as
were those younger than 40 years of age [23].
One of the important limitations of this study is its
reliance on information obtained from the respondents
about their vaccination status. There is a possibility of the
respondents overreporting vaccination; hence, we may have
overestimated the proportion of “adequately” vaccinated
respondents. A second limitation is that we asked about
the total number of HBV vaccine injections received by the
respondent, without considering the time intervals between
these injections. The third limitation is that we assumed that
all the respondents who had received 3 doses are adequately
vaccinated with or without undergoing post-vaccination
antibody assay. Five (5%) of individuals have been found
not to respond to the initial vaccination series, and this
subset of individuals should undergo a second series of three
vaccinations [24].
5. Conclusion
Hepatitis B virus infection is an important disease, pre-
ventable by vaccination and compliance with universal pre-
cautions.ThevaccinationstatusofthetheatrestaﬀinNigeria
is low and unacceptable especially with the availability of the
vaccine. To protect the patient, complete HBV vaccination
should be a prerequisite for theatre staﬀ to commence work.
Programmes designed to increase awareness relating to HBV
infection, hepatitis B vaccine, and adherence to universal
precautions are required to improve vaccination status.
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